| Pan-Phylum Characterisation of Helminth Endocannabinoid Signalling Systems | |||||
|
Tue22 Jun01:45pm(15 mins)
|
|
Bethany Crooks | |||
| Session : Drugs, Vaccines and Disease Control II | |||||
| Room: Conference room 1 | |||||
| Repurposing trypanocidal drugs to tackle amoebic gill disease in Atlantic Salmon | |||||
|
Tue22 Jun02:00pm(15 mins)
|
|
Bachar Cheaib | |||
| Session : Drugs, Vaccines and Disease Control II | |||||
| Room: Conference room 1 | |||||
| Keynote: An integrated omics approach for Fasciola hepatica vaccine target identification | |||||
|
Tue22 Jun11:00am(30 mins)
|
|
Krystyna Cwiklinski | |||
| Session : Drugs, Vaccines and Disease Control I | |||||
| Room: Conference room 1 | |||||
| Deazapurine nucleoside analogues for the treatment of Trichomonas vaginalis | |||||
|
Tue22 Jun11:45am(15 mins)
|
|
Harry De Koning | |||
| Session : Drugs, Vaccines and Disease Control I | |||||
| Room: Conference room 1 | |||||
| Keynote: Development of macrofilaricidal drugs for onchocerciasis and lymphatic filariasis | |||||
|
Fri25 Jun11:00am(30 mins)
|
|
Achim Hoerauf | |||
| Session : Drugs, Vaccines and Disease Control III | |||||
| Room: Conference room 1 | |||||
| Towards the Structure Based Design of Broad Spectrum Anti-Apicomplexan Drugs | |||||
|
Fri25 Jun11:30am(15 mins)
|
|
Ashwani Sharma | |||
| Session : Drugs, Vaccines and Disease Control III | |||||
| Room: Conference room 1 | |||||
| ACT treatment failure and resistance gene variants in African Plasmodium falciparum | |||||
|
Fri25 Jun11:45am(15 mins)
|
|
Colin Sutherland | |||
| Session : Drugs, Vaccines and Disease Control III | |||||
| Room: Conference room 1 | |||||
| Disentangling the role of Ascaris β-tubulin isotypes in the emergence of anthelmintic resistance. | |||||
|
Fri25 Jun12:00pm(15 mins)
|
|
Ben Jones | |||
| Session : Drugs, Vaccines and Disease Control III | |||||
| Room: Conference room 1 | |||||
